(Q81127034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

P Muzzin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

F Rohner-Jeanrenaud

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

28 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

S45-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system control of food intake

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Decreased central and peripheral catecholaminergic activation in obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The metabolic clearance rate of corticosterone in lean and obese male Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Cortisol effects on body mass, blood pressure, and cholesterol in the general population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Cortisol secretion in relation to body fat distribution in obese premenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistance to glucocorticoid feedback in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Skeletal muscle glucocorticoid receptor density and insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Regional distribution of 11 beta-hydroxysteroid dehydrogenase in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Tissue-specific dysregulation of cortisol metabolism in human obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Mechanisms by which Thiazolidinediones Enhance Insulin Action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

A family of tissue-specific resistin-like molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin expression and regulation in mouse pituitary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Alternative splicing generates a novel non-secretable resistin isoform in Wistar rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Comparative studies of resistin expression and phylogenomics in human and mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Dimerization of human recombinant resistin involves covalent and noncovalent interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin is expressed in pancreatic islets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin gene expression in human adipocytes is not related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Correlation between serum resistin level and adiposity in obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Resistin, central obesity, and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Increased resistin gene and protein expression in human abdominal adipose tissue.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802856

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15592486%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference